Product Name: Human IRTA2 Antibody (Cevostamab, Research Use)
Catalog Number: NBR-0427
Target Name: IRTA2
Trade Name: Cevostamab
Antibody Drug Description: Cevostamab (BFCR4350A), a bispecific antibody developed by Roche, induces durable and deep responses in heavily pre-treated patients with relapsed or refractory multiple myeloma, according to early data from a Phase 1 trial. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IRTA2
Synonyms: BXMAS1; CD307e; FCRH5; IRTA2
Target Description: May be involved in B-cell development and differentiation in peripheral lymphoid organs and may be useful markers of B-cell stages. May have an immunoregulatory role in marginal zone B-cells.
Ensembl: ENSG00000143297
Uniprot: Q96RD9